메타바이오메드

059210KOSDAQ의료용품 및 기타 의약 관련제품 제조업

65.0 / 100

Reference Date: 2026-04-13

Financial Score33.0 / 40

News Sentiment15.0 / 25

Momentum3.0 / 20

Disclosure14.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Declined 8.3% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

MetaBioMed is a company specializing in the production and sale of medical devices and materials, including dental supplies, absorbable synthetic sutures, and cosmetic materials. The company focuses on dental nerve treatment materials and synthetic sutures, with growing demand for synthetic sutures replacing traditional animal-based products and sustained growth in the dental materials market.

Number of Employees

345people

Average Salary

52.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.84Industry Average 19.898.0Point

Half of industry avg (excellent)

PBR

0.94Industry Average 1.625.5Point

Lower than industry avg (good)

ROE

9.75Industry Average -4.893.5Point

Well below industry avg

Debt Ratio

1.68Industry Average 8.888.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲11.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲42.3% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 16.9% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 0Negative 0Average Sentiment Score 70

Positive
신소재 개발 랩인큐즈, 147억원 유치 [투자 ABC]
메타바이오메드가 신소재 개발 기업 랩인큐브에 147억 원 규모의 전략적 투자를 단행하고 공동 연구개발 및 사업화 계약을 체결하여 차세대 고분자 필러 등 글로벌 의료소재 시장 확대를 위한 협력 관계를 구축했습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (8%, downtrend)

Current 4,310Won52-week high 6,52052-week low 4,110

1-month return1.0Point

1m -8.30% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

14 totalPositive 2Neutral 12Negative 0

Neutral주주명부폐쇄기간또는기준일설정2026-04-06
Neutral주주총회소집결의2026-04-06
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
Neutral정기주주총회결과2026-03-31
Neutral기업가치제고계획(자율공시)2026-03-31